Form 4: Kestra Medical Technologies Executive Sells Shares
Insider Transaction (Form 4)
Brian Daniel Webster, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 29,822 shares of common stock on July 30, 2026.
Summary
- Open-market sale: disposed of 7,857 Common Shares at $22.72 ($178,531) on July 30, 2026; holds 549,080 after (Direct).
- Open-market sale: disposed of 8,948 Common Shares at $22.60 ($202,260) on July 31, 2026; holds 540,132 after (Direct).
- Open-market sale: disposed of 13,017 Common Shares at $23.92 ($311,424) on August 3, 2026; holds 527,115 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $692,214 of stock on the open market.
Insider Transactions
Brian Daniel Webster — Director, Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Open-market sale | Common Shares | 7,857 | $23 | $178.5K | 549,080 |
| 2026-07-31 | Open-market sale | Common Shares | 8,948 | $23 | $202.3K | 540,132 |
| 2026-08-03 | Open-market sale | Common Shares | 13,017 | $24 | $311.4K | 527,115 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Open-market sale (7,857 shares) |
| 2026-07-31 | Open-market sale (8,948 shares) |
| 2026-08-03 | Open-market sale (13,017 shares) |
Keywords
insider transaction, Form 4, KMTS, KESTRA MEDICAL TECHNOLOGIES, LTD., bearish, Brian Daniel Webster
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.